Somnigroup, Leggett & Platt merger now hinges on five foreign regulators

Leggett & Platt, Incorporated (NYSE: LEG) shareholders voted at a virtual special meeting on August 20, 2026 to adopt the all-stock merger agreement under which Somnigroup International Inc. (NYSE: SGI) will acquire the diversified Missouri manufacturer, clearing the most visible remaining domestic condition on a transaction first agreed on April 13, 2026. Under the fixed exchange ratio of 0.1455 shares of Somnigroup common stock per Leggett & Platt share, former Leggett & Platt shareholders are expected to own approximately 8.6 percent of the combined company on completion, based on the record-date share counts, with Somnigroup issuing roughly 19.87 million new shares. The affirmative vote satisfies the two-thirds outstanding-share threshold required under Missouri law, but the deal still requires competition clearances in Canada, the European Union, the United Kingdom and the Republic of Korea, plus foreign investment approval in Austria, together with effectiveness of the Form S-4 registration statement. Somnigroup continues to guide investors that the transaction will close by year-end 2026, with an outside end date under the merger agreement of April 13, 2028. The central tension for Leggett & Platt holders is now less about deal certainty and more about what the fixed 0.1455 exchange ratio will actually be worth on the closing date, given how Somnigroup’s own share price has moved since April.

What did Leggett & Platt shareholders actually vote through at the August 20 special meeting?

The proposal adopted at the virtual special meeting is the definitive merger agreement, dated April 13, 2026, under which Sparrow Unity Corporation, a wholly owned Missouri subsidiary of Somnigroup International Inc., will merge with and into Leggett & Platt, Incorporated, with Leggett & Platt surviving as a direct wholly owned subsidiary of Somnigroup. Each outstanding share of Leggett & Platt common stock, other than cancelled or dissenting shares, will convert at the effective time into the right to receive 0.1455 shares of Somnigroup common stock, with cash in lieu of fractional shares. The Leggett & Platt board had unanimously recommended a vote in favour of the merger proposal, and the merger agreement required the affirmative vote of at least two-thirds of the outstanding shares entitled to vote at the meeting, with abstentions and broker non-votes counting effectively against the proposal.

Two related items were also on the agenda: an advisory vote on merger-related executive compensation, and a possible adjournment proposal to solicit additional proxies. Neither of those items carries the same gating function as the main merger proposal. With the merger proposal adopted, the remaining closing conditions are external to the Leggett & Platt shareholder base and now sit primarily with competition and foreign investment authorities in five overseas jurisdictions and with the U.S. Securities and Exchange Commission’s declaration of effectiveness for the Form S-4 registration statement covering the Somnigroup shares to be issued as merger consideration.

How does the 0.1455 exchange ratio expose Leggett & Platt holders to Somnigroup’s share price between vote and close?

The merger consideration is stock only. That is a critical fact for any Leggett & Platt shareholder trying to read the value of the deal. At Somnigroup International’s April 10, 2026 closing price, the proxy statement described an illustrative value of $11.36 per Leggett & Platt share; at Somnigroup’s July 7, 2026 closing price, the same 0.1455 ratio translated into an illustrative $10.89 per share. Since the merger agreement contains no collar mechanism to cap or floor that translation, further movement in Somnigroup’s own share price will continue to change the effective per-share economics for Leggett & Platt holders right up to the closing date.

Somnigroup itself has traded in a broad range through 2026. It stood near $88.82 on January 2, 2026, dipped to roughly $72.90 on April 2, closed around $78.59 on June 25, and was quoted near $72.71 in mid-July, against a 52-week range of $60.39 to $95.36. Truist Securities analyst Keith Hughes reduced his price target on Somnigroup International to $100 from $115 in the wake of the company’s Q2 2026 earnings release on August 6, 2026, keeping a Buy rating. The direction of Somnigroup’s share price between now and year-end 2026 will therefore materially determine what Leggett & Platt shareholders receive on the closing date, regardless of the fixed 0.1455 ratio adopted at the August 20 meeting.

For arbitrage-oriented holders, the implication is straightforward: the deal spread reflects both time value to closing and the residual regulatory-timing risk in the five foreign jurisdictions. Leggett & Platt stock closed near $9.56 on August 17, 2026, against a 52-week range of $8.34 to $13.00, with a market capitalisation of about $1.31 billion. That leaves a visible gap to the illustrative deal values disclosed in the proxy, but the size of that gap will be tested in real time as Somnigroup’s share price moves and as each foreign approval either lands or slips.

Which five foreign regulatory clearances now determine when the Somnigroup, Leggett & Platt merger actually closes?

The U.S. Hart-Scott-Rodino Antitrust Improvements Act waiting period expired on June 3, 2026, removing the primary domestic antitrust hurdle. What remains is a five-jurisdiction runway. The companies disclosed that completion requires clearances under competition laws in Canada, the European Union, the United Kingdom and the Republic of Korea, together with a foreign investment clearance in Austria. Each of those regimes carries its own review timetable and its own scope for remedies, undertakings or extended-phase reviews. None of the five is publicly signalled as unusually contentious given the parties’ respective footprints, but each is a discrete gating item on the path to a year-end 2026 close.

Two contractual features frame the risk allocation between the parties. The merger agreement contemplates a termination fee of $80 million payable by Somnigroup International if specified regulatory approvals fail, and a termination fee of $64 million payable by Leggett & Platt in scenarios involving a superior proposal or a change of recommendation. The asymmetry is analytically useful: it reflects that the parties viewed foreign regulatory execution as a cost carried primarily by the acquirer, while target-side deal protection sits with a smaller superior-proposal fee. The outside end date of April 13, 2028 gives the parties substantial runway to work through remedies if any of the foreign reviews extend beyond the year-end 2026 target.

What does Leggett & Platt bring to Somnigroup beyond bedding components and mattress supply relationships?

Leggett & Platt is not a pure bedding business. Its Bedding Products segment supplies innersprings, adjustable bases and private-label finished mattresses to bedding manufacturers, but the company also operates a Specialized Products segment that produces automotive seating components including lumbar support, seat suspension systems, motors and actuators, together with engineered hydraulic cylinders for aerospace and mobile-equipment original equipment manufacturers. A third segment, Furniture, Flooring and Textile Products, produces steel motion hardware, springs and seat suspensions for soft seating, office-chair components, and carpet cushion and flooring underlayment.

That diversification changes the integration profile relative to Somnigroup International’s earlier addition of Mattress Firm, which was a pure U.S. specialty retail distribution asset. Somnigroup previously indicated that Leggett & Platt would operate as a separate business unit within the group, similar to the way Tempur Sealy, Mattress Firm and Dreams sit as distinct units, with its head office remaining in Carthage, Missouri. That model implies that the automotive, aerospace and furniture-adjacent product lines will not be immediately dismantled or absorbed. It also implies a more complex synergy narrative than a straight bedding roll-up, because the near-term overlap sits inside the Bedding Products segment, while the value case for the Specialized Products and Furniture, Flooring and Textile Products segments depends on either continued standalone operation, selective portfolio review over time, or eventual divestiture.

How does adding Leggett & Platt fit Somnigroup’s post-Mattress Firm leverage discipline?

Somnigroup entered 2026 carrying material leverage from the Mattress Firm combination completed in February 2025, with consolidated net debt of roughly $4.9 billion and a leverage ratio near 3.6x under its credit facility as of the earlier Mattress Firm disclosures, exiting 2025 at approximately 3.35x and management guiding to a return to its stated 2x to 3x target range during 2026. The Leggett & Platt transaction is entirely stock-financed, which means Somnigroup is not layering fresh acquisition debt onto the balance sheet to fund the equity consideration. That structural choice preserves the deleveraging path management laid out.

However, Somnigroup will inherit Leggett & Platt’s own balance sheet on completion, including its outstanding indebtedness and pension obligations. The pro forma leverage impact therefore depends on Leggett & Platt’s net debt at close, not on the transaction consideration itself. Somnigroup reported 2025 revenue of $7.48 billion and net earnings of about $384 million, and its Q2 2026 earnings on August 6, 2026 were followed by the Truist price-target reduction cited above, alongside commentary on softer bedding demand. The combined entity will therefore be tested in 2026 and 2027 on two fronts: whether the pro forma leverage ratio lands inside management’s stated corridor, and whether Leggett & Platt’s diversified operating cash flow strengthens or diluted Somnigroup’s post-Mattress Firm free cash flow profile.

What does Karl Glassman’s 12-month post-close transition suggest about Leggett & Platt operating continuity?

Karl G. Glassman, Chairman and Chief Executive Officer of Leggett & Platt, is expected to continue leading Leggett & Platt following the closing date and to assist with a seamless transition to a new Chief Executive Officer of the Leggett & Platt business unit within twelve months of closing. That is a longer continuity commitment than would be typical for a target-company chief executive in a straightforward absorption, and it signals two things. First, Somnigroup International intends to preserve Leggett & Platt as an operating unit with its own leadership rather than folding it immediately into a broader Somnigroup structure. Second, the Leggett & Platt board has secured a leadership bridge that keeps institutional knowledge on the diversified product portfolio in place through the first year of ownership.

The company also indicated that most of Leggett & Platt’s management team and employees are expected to be retained, and that the Carthage, Missouri head office will continue to operate. Together with the separate-business-unit design, these features suggest that day-to-day operational disruption during the first post-close year is intended to be limited, at least at the segment leadership and site level.

Which specific closing events should investors watch between now and year-end 2026 completion?

The next twelve to sixteen weeks will produce a series of observable proof points that will together determine whether the year-end 2026 closing guidance holds. The first is the sequence of foreign regulatory decisions in Canada, the European Union, the United Kingdom, the Republic of Korea and Austria, either as unconditional clearances, clearances with undertakings, or extended-phase reviews. Somnigroup International’s next scheduled quarterly earnings release, alongside its Q3 2026 investor commentary, will offer management’s own update on the integration planning and regulatory timetable. The behaviour of Somnigroup’s share price will directly determine the realised consideration value for Leggett & Platt holders under the fixed 0.1455 exchange ratio.

Two more procedural items warrant attention. Missouri appraisal rights under Section 351.455 of the General and Business Corporation Law of Missouri are available to eligible Leggett & Platt shareholders who properly perfect those rights, which introduces a small potential source of cash outflow tied to any dissenting-share process. And on closing, Leggett & Platt common stock will be delisted from the New York Stock Exchange, ending its long-running index and dividend history as an independent listed company. What has improved is the deal’s certainty of consideration on the target side: the shareholder vote is behind the transaction, and the U.S. antitrust review is behind it. What remains unresolved is the pace and scope of foreign regulatory clearance and the level at which Somnigroup shares trade on the closing date. The clearest evidence that would strengthen the current investment case is a rapid, condition-free set of clearances in the five foreign jurisdictions accompanied by continued Somnigroup share-price stability; the clearest evidence that would weaken it is a foreign regulator moving to an extended-phase review or Somnigroup share-price drift materially below the illustrative reference levels disclosed in the proxy.

What should investors track between the August 20 approval and year-end completion of the Leggett & Platt, Somnigroup merger?

• Leggett & Platt, Incorporated shareholders voted at the August 20, 2026 virtual special meeting to adopt the all-stock merger agreement with Somnigroup International Inc., clearing the two-thirds outstanding-share threshold and the most visible remaining U.S. condition.
• Each Leggett & Platt common share will convert into 0.1455 shares of Somnigroup common stock on completion, with cash in lieu of fractional shares, and former Leggett & Platt holders will own approximately 8.6 percent of Somnigroup based on record-date share counts.
• Somnigroup International expects to issue approximately 19.87 million new shares as merger consideration, based on the July 6, 2026 record date, with the transaction structured to qualify as a tax-free reorganisation.
• The U.S. Hart-Scott-Rodino Antitrust Improvements Act waiting period expired on June 3, 2026, but the merger still requires competition clearances in Canada, the European Union, the United Kingdom and the Republic of Korea, together with foreign investment approval in Austria.
• The merger agreement contains an $80 million termination fee payable by Somnigroup International in specified regulatory-failure scenarios and a $64 million termination fee payable by Leggett & Platt in specified superior-proposal or change-of-recommendation scenarios, with an outside end date of April 13, 2028.
• The consideration value for Leggett & Platt holders is not fixed in dollar terms; illustrative values disclosed in the proxy statement were $11.36 per Leggett & Platt share based on Somnigroup’s April 10, 2026 close and $10.89 based on its July 7, 2026 close.
• Leggett & Platt is a diversified manufacturer covering bedding components, automotive seating systems, hydraulic cylinders for aerospace and mobile equipment, furniture and flooring components, giving the combined group a different integration profile from the earlier Mattress Firm combination.
• Somnigroup International intends to operate Leggett & Platt as a separate business unit within the group alongside Tempur Sealy, Mattress Firm and Dreams, with Karl G. Glassman continuing as leader of the unit through a Chief Executive Officer transition within twelve months of closing.
• The all-stock structure preserves Somnigroup’s post-Mattress Firm deleveraging path, but pro forma leverage on close will depend on Leggett & Platt’s own net debt position, not on the equity consideration itself.
• The next observable proof points are the timing and conditionality of the five foreign clearances, Somnigroup International’s next quarterly earnings and integration commentary, and Somnigroup’s share price behaviour through the closing window, all of which will together determine the realised deal value under the fixed 0.1455 exchange ratio.